You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Norethindrone And Ethinyl Estradiol (7/14), and what generic alternatives are available?

Norethindrone And Ethinyl Estradiol (7/14) is a drug marketed by Watson Labs Teva and Watson Labs and is included in two NDAs.

The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Drug patent expirations by year for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
Recent Clinical Trials for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of VirginiaEarly Phase 1
CelerionPhase 1
Achillion, a wholly owned subsidiary of AlexionPhase 1

See all NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)

US Patents and Regulatory Information for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) ethinyl estradiol; norethindrone TABLET;ORAL-21 071041-001 Sep 24, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) ethinyl estradiol; norethindrone TABLET;ORAL-28 071042-001 Sep 24, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.